Skip Ribbon Commands
Skip to main content
Sign In

Pages :bUse SHIFT+ENTER to open the menu (new window).Open MenuOpen Menu
This system library was created by the Publishing feature to store pages that are created in this site.

Synonyms, Keywords
Test Components
26106OMSC1B2B CBC with Auto Differential
HGMPS and AD: (White blood cell count, red blood cell count, hemoglobin, hematocrit, mean corpuscular volume, mean corpuscular hemoglobin, mean corpuscular hemoglobin concentration, red cell distribution width, platelet, mean platelet volume, percent/absolute neutrophils, lymphocytes, monocytes, eosinophils, and basophils.​)
 
Certain results and instrument flags will reflex peripheral smear review.  Click on the link below to view slide review criteria.
 
26105OMRUAB2B Urine (Dipstick & Micro)
​STIX and Micro: (Color, Turbidity, Specific Gravity, pH, Protein, Glucose, Ketone, Bile, Blood, Urobilinogen, Esterase, and Nitrite, Casts, Renal Epithelial cells, WBC, RBC, Squamous cells, and Bacteria).
25525BABGSOBabesia microti IgG Antibodies, Serum (BABG)

​Babesiosis Serology

25230BABNATBabesia microti, Nucleic Acid Test
Babesia PCR, Babesiosis PCR
22343BABEBabesia Smear
​Babesia microti, Giemsa Stain​
26138BRBPSSOBacteria PCR & Sequence (BRBPS)
16S rRNA gene sequencing
Bacterial sequencing
Broad range
Broad-range
16S
Broad
Mycobacteria
Mycobacterial
Ribosomal RNA
rRNA
Sequencing
Next Generation Sequencing
NGS

If polymerase chain reaction (PCR) testing is negative, no sequencing is performed, and the test is resulted as negative.

If PCR testing is positive, sequencing is performed. Strong positive results are first submitted to Sanger sequencing, which can yield results in as few as 4 days. Weak positive results, or Sanger sequencing results that are mixed, are submitted to next-generation sequencing (ie, targeted metagenomics testing).

26122MISCBacterial Culture, Cystic Fibrosis with Antimicrobial Susceptibilities (CFRCS)
22345BARBarbiturates, Urine
Amobarbital, Amytal, Phenobarbital, Luminal, Nembutal, Pentobarbital. Secobarbital, Seconal, Solfoton , Phenobarbital, Butalbital, Fiorinal​
25091CO-BARBarbiturates, Urine, Confirm Only by GCMS
Amobarbital, Amytal, Phenobarbital, Luminal, Nembutal, Pentobarbital. Secobarbital, Seconal, Solfoton, Phenobarbital, Butalbital, Fiorinal​
25412BARTPANBartonella Ab Panel, IgG & IgM (BART)
​Bartonella henselae Abs, IgG/IgM; Bartonella quintana, IgG/IgM; Cat Scratch Disease, Bartonellosis, BART
26208BCLLSOB-Cell IGH Hypermutation Analysis (BCLL)

​BCLL
IGVH
IGHV
Next Gen Sequencing Test
Somatic mutation (or Hypermutation)
CLL prognosis

26451BALLMSOB-Cell Lymphoblastic Leukemia Monitoring, Minimal Residual Disease Detection, Flow Cytometry, Varies (BALLM)     

​Acute Minimal Residual Disease, ALL-MRD, B-ALL MRD, B-cell ALL MRD

25628BLYMFSOB-Cell Lymphoma Tissue, FISH (BLYM)

BLYM
BCL2 (18q21) rearrangement
BCL6 (3q27) rearrangement
Burkitt lymphoma
Burkitt-like lymphoma
CCND2
Diffuse Large Cell Lymphoma/"Double Hit"
Follicular lymphoma
Large BCL with IRF4 rearranged
MALT (18q21) rearrangement
MALT lymphoma
Mantle Cell Lymphoma (MCL)
MYC (8q24.1) rearrangement
MYC/Kappa
MYC/Lambda
Splenic Marginal Zone Lymphoma
t(11;14) (q13;q32) - CCND1/IGH
t(11;18) (q21;q21) - BIRC3/MALT1
t(14;18) (q32;q21) - IGH/MALT1
t(14;18)(q32;q21) - IGH/BCL2
t(2;8)(p12;q24) - IGK/MYC
t(8;14) (q24.1;q32) - MYC/IGH
t(8;22) (q24.1;q11.2) - MYC/IGL
IRF4
DUSP22
TNFRSF14
1p36

TI BLYMFSO

This test does not include a pathology consultation. If a pathology consultation is desired, PATHC / Pathology Consultation should be ordered and the appropriate FISH test will be ordered and performed at an additional charge. Mayo Hematopathology Consultants are involved in both the preanalytic (tissue adequacy and probe selection, when applicable) and postanalytic (interpretation of FISH results in context of specific case, when applicable) phases.

Depending on the lymphoma subtype suspected, the most appropriate probes to order are listed in the table: Common Chromosome Abnormalities in B-cell Lymphomas in Clinical Information.

If the patient is being tracked for known abnormalities, indicate which probes should be used.

A charge and CPT code is applied for each probe set hybridized, analyzed, and reported.

Initial probe sets are run and completed within 4 days. If, based on testing algorithms, results of the initial probe sets require reflex testing, complete results will be available within 10 days. 

25401BCRAMSOBCR/ABL, p210, RT-PCR(BCRAB)
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
B lymphoblastic leukemia (B-ALL)
T lymphoblastic leukemia (T-ALL)
BCR-ABL1
BCR ABL
BCR/ABL
Chronic myelogenous leukemia (CML)
Philadelphia chromosome, Ph bone marrow/blood
t(9;22)
Tyrosine kinase inhibitor (TKI) therapy monitoring, PCR
25411BCRADSOBCR/ABL-1 RNA-Qual Diagnostic (BADX)
Philadelphia chromosome Ph bone marrow/blood
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
BCR-ABL1
BCR ABL
BCR/ABL
B lymphoblastic leukemia (B-ALL)
Chronic myelogenous leukemia (CML)
Chronic myeloid leukemia
T lymphoblastic leukemia (T-ALL)
t(9;22)

​This test is only qualitative and should not be used for routine monitoring (ie, quantitative mRNA level).

Monitoring of most patients with chronic myeloid leukemia (CML) should be performed using BCRAB / BCR/ABL, p210, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Chronic Myelogenous Leukemia (CML), Varies.

Monitoring of patients known to carry a p190 fusion should be performed using BA190 / BCR/ABL, p190, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Assay, Varies.

25546BC190SOBCR/ABL1, p190, mRNA Detection, Reverse Transcription-PCR (RT-PCR), Quantitative, Monitoring Assay, Varies (BA190)
Philadelphia chromosome, Ph bone marrow/blood
Acute lymphoblastic leukemia (ALL)
Acute myeloid leukemia (AML)
B lymphoblastic leukemia (B-ALL)
BCR ABL
BCR/ABL
BCR-ABL1
T lymphoblastic leukemia (T-ALL)
t(9;22)
26479BAKDMSOBCR/ABL1, Tyrosine Kinase Inhibitor Resistance, Kinase Domain Mutation Screen, Sanger Sequencing, Varies (BAKDM)

​E255K, E355G, F317L, F369V, G250E, H396R, M244V, M351T, Q252H, T315I, Y253F, Y253H, T315A, V299L, Tyrosine kinase inhibitor (TKI), Kinase domain mutation, ABL, Imatinib resistance, Chronic myeloid leukemia, Chronic myelogenous leukemia (CML), BCR-ABL1, BCR/ABL, BCR ABL, Acute lymphoblastic leukemia (ALL)

22346BENZBenzodiazepines, Urine
Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Lorazepam, Xanax, Librium, Valium, Ativan, Serax, Restoril​, Date Rape Drug, 7-Aminoflunitrazepam, Roofies, Rohypnol
​The immunoassay screening test for the Benzodiazepines drug class does not detect Lorazepam or Clonazepam well.  If either of these drugs are suspected, please order the test “Benzodiazepines, Urine, Confirm Only by LC/MSMS” in addition to this test to insure detection if present.
25092CO-BENZBenzodiazepines, Urine, Confirm Only by LCMS/MS
Clonazepam, Temazepam, Diazepam, Chlordiazepoxide, Alprazolam, Flunitrazepam, Flurazepam, Nordiazepam, Chlorazepate, Lorazepam, Xanax, Librium, Valium, Ativan, Serax, Restoril​, Date Rape Drug, 7-Aminoflunitrazepam, Roofies, Rohypnol
23169B2IGABeta 2 Glycoprotein 1 IgA
B2IgA, Beta 2 Glycoprotein
23168B2IGGBeta 2 Glycoprotein 1 IgG
B2IgG, Beta 2 Glycoprotein​
23167B2IGMBeta 2 Glycoprotein 1 IgM
B2IgM, Beta 2 Glycoprotein​
26319B2IGABeta 2 Glycoprotein 1, IgA

​Anti-Phospholipid Antibodies, Antiphospholipid Antibodies, Antiphospholipid syndrome, APS, anti-B2-GP1 antibodies, Beta 2 glycoprotein, Beta-2 glycoprotein, Beta-2 GP1, systemic lupus erythematosus, SLE

26320B2IGGBeta 2 Glycoprotein 1, IgG

​ Anti-Phospholipid Antibodies, Antiphospholipid Antibodies, Antiphospholipid syndrome, APS, anti-B2-GP1 antibodies, Beta 2 glycoprotein, Beta-2 glycoprotein, Beta-2 GP1, systemic lupus erythematosus, SLE

26321B2IGMBeta 2 Glycoprotein 1, IgM

​Anti-Phospholipid Antibodies, Antiphospholipid Antibodies, Antiphospholipid syndrome, APS, anti-B2-GP1 antibodies, Beta 2 glycoprotein, Beta-2 glycoprotein, Beta-2 GP1, systemic lupus erythematosus, SLE

22347B2MBeta-2 Microglobulin
B2M​, B2MICRO
26449B2MRUSOBeta-2 Microglobulin, Random, Urine (B2MU)

​B2MRUSO, U B2MRUSO, Beta-2 Microglobulin, Urine (FB2MU), Beta-2 Microglobulin, Urine (B2MU), Beta 2 Microglobulin Test, Beta-2 Microglobulin, Urine, B2M, (Beta-2 Microglobulin) Urine

24795B2TRNSOBeta-2 Transferrin: Detection of Spinal Fluid in Other Body Fluid (BETA2)

B2 Transferrin; Cerebrospinal Fluid Leakage; CSF Specific Transferrin; CSF-Specific Transferrin; Otorrhea, Spinal Fluid;
Rhinorrhea, Spinal Fluid; Tau Protein; Transferrin B2; Transferrin, Spinal Fluid

BF B2TRNSO

24970BCTXSOBeta-Crosslaps (Beta-CTx), Serum (CTX)
B-CTx, Beta CrossLaps, Beta-CTx, C-Telopeptide, C-terminal collagen crosslinks, Carboxy terminal collagen crosslinks, CTx
22242BOHBeta-Hydroxybutyrate
Hydroxybutyrate, Ketones, 3-hydroxybutyrate
22244CO2Bicarbonate
HCO3, CO2, Total CO2​
24984BACIDSOBile Acids, Total Serum (BILEA)

Bile Salts Total

Bile Acids, Total, Serum (BILEA)

26446UBILALSOBile Alcohols, Urine

​URINARY BILE ALCOHOL 5b-CHOLESTANE-3a,7a,12a,23S,25-PENTOL, TOTAL

22246BILE-UBile, Urine
Bilirubin, Urine​
22248DBILBilirubin, Direct Only
DBIL, Conjugated Bilirubin​, Fractionated Bilirubin
22249NBILIBilirubin, Neonatal
NBili, Neonatal Bilirubin​
Total Bilirubin, Direct Bilirubin
Indirect Bilirubin will be calculated​
22250TBILBilirubin, Total Only
TBil, Total Bilirubin​
22251TBIL-OBilirubin, Total, Other Body Fluids
Body Fluid Total Bilirubin​
23318BIOTESOBioavailable Testosterone, Total and Free (TTFB)
​Androgens, Bioavailable Testosterone, NonSex Hormone Binding Globulin (SHBG), Testosterone Group, Testosterone, Total Only, Serum

​Testosterone, Total

Testosterone, Free

Testosterone, Bioavailable

26323MISCBiogen Program, Alzheimer Disease Evaluation, Spinal Fluid (ADBIO)

​Abeta, Amyloid Beta 42, Beta-Amyloid 42, Phosphorylated Tau, pTau, Total Tau, tTau, ADBIO, BIOGEN, AdMark, ADEVL

22252BIOTSSOBiotinidase, Serum (BIOTS)
Biotin-amide amidohydrolase, Biotinidase deficiency, BTD
26335PBKQNSOBK Virus DNA Detection and Quantification, Plasma (PBKQN)

BK viral load

BK virus by PCR

BK virus DNA quant

BKV by PCR

BKV DNA quant

BKV viral load

BK Virus PCR, Qnt, Plasma

26343BLASTSOBlastomyces Antibody, Enzyme Immunoassay, Serum (BLAST)

​Blastomycosis, Fungal Serology

26173BLCAGSOBlastomyces Quantitative Antigen, CSF and BAL (316)

Blastomyces Quant Ag, CSF and BF (316)

​FL BLCAGSO

25016BLSAGSOBlastomyces Quantitative Antigen, Serum (316)
​Blastomyces Dermatitidis QNT AG
25581BLUAGSOBlastomyces Quantitative Antigen, Urine (316)

​Blastomyces Dermatitidis QNT AG

U BLUAGSO

26100CHR2NICBLIPO, Glucose and Nicotine
​Concert Health, CHR
​Includes GLU, BLIPO (Total Cholesterol, HDL Cholesterol, Triglyceride, calculated LDL cholesterol and NONHDL Cholesterol), and NICTS (Nicotine and Metabolites).
22256ABGHBlood Gases and Hemoglobin, Arterial
Art. Blood Gas w/Hgb ​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Hemoglobin results.​
22257VBGHBlood Gases and Hemoglobin, Venous
Venous Bld Gases w/Hgb​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), and Hemoglobin​
22258ABGLBlood Gases and NA/K/IC, Arterial
Blood Gas, Art. w/ Sodium, Potassium, Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Sodium, Potassium, and Ionized Calcium​
22259CBGLBlood Gases and Na/K/Ic, Capillary
Blood Gas, Cap. w/ Sodium, Potassium, Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation), Sodium, Potassium, and Ionized calcium​
22260VBGLBlood Gases and Na/K/Ic, Venous
Ven.Bld.Gases & Na/K/Ion.Ca ​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), Sodium, Potassium, and Ionized calcium​
22261ABGBlood Gases, Arterial
Art.Blood Gas, ABG, PCO2, PO2​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation)​
22262CBGBlood Gases, Capillary
CBG, Capillary Blood Gases​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation)​
22265VBGNAKBlood Gases, Na/K, Venous
Venous Bld, Gases & Na/K​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only), Sodium, and Potassium​
22264VBGLHBlood Gases, Na/K/Ic and Hemoglobin, Venous
Ven.Bld.Gases & Na/K/Ion.Ca w/Hgb​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation calculated HCO3-Marshfield Only), Sodium, Potassium, Ionized calcium, and Hemoglobin​
22263ABGLHBlood Gases, NA/K/IC, AND Hemoglobin, Arterial
Blood gas with Hgb, Sodium, Potassium and Ionized Calcium​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, bicarbonate HCO3, base excess BE, O2 Saturation) and Sodium, Potassium, Ionized Calcium, and Hemoglobin results.​
22266UABGBlood Gases, Umbilical Cord Arterial
Cord Gas, Arterial

Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2,  base excess BE)​

22267UVBGBlood Gases, Umbilical Cord Venous
Cord Gas, Venous​

Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2,  base excess BE)​

22268VBGBlood Gases, Venous
Venous Blood Gases, VBG​
Panel includes Blood Gas (pH, partial pressure of carbon dioxide pCO2, partial pressure of oxygen pO2, base excess BE, O2 Saturation, calculated HCO3-Marshfield Only) ​
22269ABO/RHBlood Typing, ABO and RH
​ABO Grouping, ABO/RH, Type and Rh, ABO/RH Typing, BB - Blood Type, ABO & Rh
26459COGBFSOB-Lymphoblastic Leukemia/Lymphoma, Children's Oncology Group Enrollment Testing, FISH (COGBF)

+4,+10,+17

17p- (17p deletion) or TP53

9p- (9p deletion) or CDKN2A or p16

ABL1 (9q34) rearrangement

ABL2 (1q25) rearrangement

BCR-ABL1 like ALL

CRLF2 (Xp22.33) or (Yp11.32) rearrangement

Hyperdiploidy

iAMP21

IGH (14q32) rearrangement

JAK2 (9p24.1) rearrangement

MLL or KMT2A (11q23) rearrangement

MYC (8q24.1) rearrangement

P2RY8 (Xp22.33) or (Yp11.32) rearrangement

PDGFRB (5q33) rearrangement

IKZF1 deletion

Ph-like ALL

t(1;19)(q23;p13.3) - PBX1/TCF3

t(10;11)(p12;q23) - MLLT10/MLL or AF10/MLL

t(11;19)(q23;p13.1) - MLL/ELL

t(11;19)(q23;p13.3) - MLL/MLLT1 or MLL/ENL

t(12;21)(p13;q22) - TEL/AML1 or ETV6/RUNX1

t(4;11)(q21;q23) - AFF1/MLL or AF4/MLL

t(6;11)(q27;q23) - MLLT4/MLL or AF6/MLL

t(9;11)(p22;q23) - MLLT3/MLL or AF9/MLL

t(X;14)(p22.3;q32) - CRLF2/IGH

Hypodiploid/pseudo-hyperdiploid

Hypotriploid/Near-Triploid

Philadelphia-like ALL

t(9;22)(9q34;q11.2) - BCR/ABL1

t(Y;14)(p11.32;q32) - CRLF2/IGH

12p13 rearrangement, ETV6

Children's Oncology Group, COG

The FISH panel includes testing for the following abnormalities using the fluorescence in situ hybridization (FISH) probes listed:

+9/9p-, CDKN2A/D9Z1

t(9;22) BCR/ABL1

11q23 rearrangement, MLL (KMT2A) break-apart

-17/17p-, TP53/D17Z1

t(1;19)(q23;p13), PBX1/TCF3

Hyperdiploidy, +4,+10,+17: D4Z1/D10Z1/D17Z1

t(12;21)(p13;q22), ETV6/RUNX1 fusion and iAMP21

14q32 rearrangement, IGH break-apart

t(Xp22.33;var) or t(Yp11.32;var), P2RY8 rearrangement

t(Xp22.33;var) or t(Yp11.32;var), CRLF2 rearrangement

8q24.1 rearrangement, MYC break-apart

If the FISH panel demonstrates normal or nonclassical abnormalities, BALPF / B-Cell Acute Lymphoblastic Leukemia/Lymphoma (ALL), FISH, Pediatric Varies panel will be performed.

The Philadelphia chromosome-like acute lymphoblastic leukemia (Ph-like ALL)panel includes testing for the following kinase activating chromosome abnormalities, using the FISH probes listed below as well as IKZF1 deletion, which often accompanies Ph-like ALL:

1q25 rearrangement, ABL2 break-apart

5q33 rearrangement, PDGFRB break-apart

9p24.1 rearrangement, JAK2 break-apart

9q34 rearrangement, ABL1 break-apart

7p-, IKZF1/CEP7

When an MLL (KMT2A) rearrangement is identified, reflex testing will be performed to identify the translocation partner. Probes include identification of:

t(4;11)(q21;q23) AFF1/MLL

t(6;11)(q27;q23) MLLT4(AFDN)/MLL

t(9;11)(p22;q23) MLLT3/MLL

t(10;11)(p12;q23) MLLT10/MLL

t(11;19)(q23;p13.1) MLL/ELL

t(11;19)(q23;p13.3) MLL/MLLT1

When an IGH and/or CRLF2 rearrangement is identified, reflex testing will be performed using the CRLF2/IGH fusion probe set to identify a potential t(X;14)(p22.33;q32) or t(Y;14)(p11.32;q32) cryptic translocation.

In the absence of BCR/ABL1 fusion, when an extra ABL1 signal is identified, reflex testing will be performed using the ABL1 break-apart probe set to evaluate for the presence or absence of an ABL1 rearrangement.

In the absence of ETV6/RUNX1 fusion, when an extra ETV6 signal is identified, reflex testing will be performed using the ETV6 break-apart probe set to evaluate for the presence or absence of an ETV6 rearrangement.

If a MYC rearrangement is identified, both the BCL2 and BCL6 probe sets will be performed.

25460BFCCBody Fluid Cell Count
​Cell Count Body Fluid, BF Cell Ct
​Total Nucleated Cell Count (WBC), Red Blood Cell Count
22415BFCC/DBody Fluid Cell Count and Manual Differential (Not CSF)
Cell Count and Differential, Body Fluid, BFD Cell Ct + Diff​
Total Nucleated Cell Count (WBC), Red Blood Cell Count, Percent neutrophils, lymphocytes, monocytes, eosinophils, and basophils and any abnormal nucleated cells present including blasts and nucleated red blood cells.​
25463BAPBone Alkaline Phosphatase
Bone-specific Alkaline phosphatase, Ostase
22381B.M.Bone Marrow Differential
​Bone Marrow Biopsy, Bone Marrow Aspirate, Bone Marrow Exam
23165BORDPCRBordetella by PCR
​Pertussis PCR, Whooping Cough by PCR, Parapertussis PCR
25560BRAFDSOBRAF V600E/V600K Somatic Mutation Analysis, Tumor (BRAFD)

Anaplastic thyroid carcinoma
BRAF
BRAF mutation
BRAFD
Brain cancer
Circulating tumor cells
Circulating tumor DNA
CNS tumor
Colon cancer
Colorectal cancer
Craniopharyngioma
Erdheim-Chester disease
Glioma
Hairy Cell leukemia
Histiocytic lesion
Liquid biopsy
Lung cancer
Melanoma
Papillary thyroid carcinoma
V600E
V600K

Slide review, BRAF Mutation Analysis
23094CA2729Breast Cancer Antigen (CA 27.29)
Biomira Truquant BR, Breast Cancer Tumor Markers, Breast Carcinoma, Cancer Antigen 27.29 , (CA 27.29), MAM 6, Milk Mucin, CA 27-29
22383BCABreast Cancer Antigen 15-3
Breast Ca Ag 15-3 (BCA)​
22384BRUCSOBrucella Abortus Serology (SS02002)
 Brucellosis, Undulant fever, B. abortus, Brucellosis Agglutinins

Quantitative direct agglutination procedure for the detection of antibody to B. abortus, B. melitensis, and B. suis.

Antibodies to Brucella canis, a rare cause of brucellosis, are not detected by this method.​

23109BNPB-Type Natriuretic Peptide
​BNP, Brain-type Natriuretic peptide
26078BPSOBullous Pemphigoid, BP180 & BP230, IgG Antibodies, Serum (BPAB)

BP 180

BP 230

Bullous Pemphigoid

25152BUPBuprenorphine, Urine
Buprenex, Suboxone, Subutex, Temgesic​
25374CO-BUPBuprenorphine, Urine, Confirm Only by LCMS
Buprenex, Suboxone, Subutex, Temgesic​
23249BUPRSOBupropion, Serum (178)
Wellbutrin®; Zyban®